Add to your lists

Recommended Content

Picture of All-In Podcast
All-In Podcast

LA's Wildfire Disaster, Zuck Flips on Free Speech, Why Trump Wants Greenland

Jan. 11, 2025, 2:08 a.m.

No Paywall
Picture of Tech Investment Ideas
Tech Investment Ideas
Website logo

ASML's Strategy to Extend Moore's Law

Jan. 7, 2025, 9:50 a.m.

No Paywall
Picture of Platformer
Platformer
Website logo

OpenAI says it knows how to make superintelligence now

Jan. 7, 2025, 1:32 a.m.

Some Paywall
Picture of Tanay’s Newsletter
Tanay’s Newsletter
Website logo

Comparing the Financials of Databricks and Snowflake

Dec. 30, 2024, 11:35 p.m.

No Paywall
Picture of The Entertainment Strategy Guy
The Entertainment Strategy Guy
Website logo

The Future of TV or Just Another Netflix Hit?

Dec. 19, 2024, 12:10 a.m.

No Paywall
FinBrowser logo
Login Sign Up

How would you rate this source in terms of content quality?
Source Picture

BioPharma Dive

Picture of BioPharma Dive

Tags

Online Publication

Similiar Sources

Picture of Biopharma Reporter
Biopharma Reporter
Biotech - News 8.0
Picture of Cafepharma
Cafepharma
Biotech - News 8.0
Picture of Drug Delivery Business
Drug Delivery Business
Biotech - News 8.0
Picture of Drugs.com
Drugs.com
Biotech - News 8.0
Picture of Evaluate
Evaluate
Biotech - News 8.0
Picture of Fierce Biotech
Fierce Biotech
Biotech - News 8.0
Picture of GEN
GEN
Biotech - News 8.0
Picture of Labiotech
Labiotech
Biotech - News 8.0
Picture of Pharmafile
Pharmafile
Biotech - News 8.0
Picture of PharmaLive
PharmaLive
Biotech - News 8.0

Summary

Sector Biotech
Content Type News
Website Other
Paywall No

Ratings

Average Rating 8.0
Ratings 1
Your Rating Rate
Ranking 707

Content

Picture of BioPharma Dive
BioPharma Dive
Website logo

J&J joins Pfizer in detailing impact of Part D redesign

Jan. 22, 2025, 4:27 p.m.

No Paywall
Picture of BioPharma Dive
BioPharma Dive
Website logo

J&J oncology sales grow, but shares slide on outlook

Jan. 22, 2025, 4:24 p.m.

No Paywall
Picture of BioPharma Dive
BioPharma Dive
Website logo

Intellia makes progress on HAE study; 2 more China drug deals

Jan. 22, 2025, 3 p.m.

No Paywall
Picture of BioPharma Dive
BioPharma Dive
Website logo

AstraZeneca, Daiichi’s Enhertu successor gets first FDA OK in breast cancer

Jan. 21, 2025, 5:13 p.m.

No Paywall
Picture of BioPharma Dive
BioPharma Dive
Website logo

Moderna gets $590M from US government for bird flu vaccine

Jan. 21, 2025, 4:59 p.m.

No Paywall
Picture of BioPharma Dive
BioPharma Dive
Website logo

Trump reverses Biden healthcare directives, orders WHO withdrawal

Jan. 21, 2025, 3:50 p.m.

No Paywall
Picture of BioPharma Dive
BioPharma Dive
Website logo

Sionna, Odyssey join queue of biotechs testing investors’ IPO interest

Jan. 21, 2025, 3 p.m.

No Paywall
Picture of BioPharma Dive
BioPharma Dive
Website logo

What will 2025 hold for biopharma?

Jan. 21, 2025, 10 a.m.

No Paywall
Picture of BioPharma Dive
BioPharma Dive
Website logo

Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy.

Jan. 17, 2025, 5:31 p.m.

No Paywall
Picture of BioPharma Dive
BioPharma Dive
Website logo

Novo shares high-dose Wegovy results; Amgen, AstraZeneca drugs get expanded OKs

Jan. 17, 2025, 5 p.m.

No Paywall
Picture of BioPharma Dive
BioPharma Dive
Website logo

Ozempic, Ibrance among next drugs picked by Medicare for price talks

Jan. 17, 2025, 1:11 p.m.

No Paywall
Picture of BioPharma Dive
BioPharma Dive
Website logo

‘The bar has risen’: China’s biotech gains push US companies to adapt

Jan. 16, 2025, 5:24 p.m.

No Paywall
Picture of BioPharma Dive
BioPharma Dive
Website logo

Roche’s new deals head tries to navigate a more ‘complicated’ and ‘expensive’ biotech world

Jan. 16, 2025, 5:22 p.m.

No Paywall
Picture of BioPharma Dive
BioPharma Dive
Website logo

Lilly’s Omvoh approved by FDA for Crohn’s

Jan. 16, 2025, 3:26 p.m.

No Paywall
Picture of BioPharma Dive
BioPharma Dive
Website logo

JPM25: The FDA’s future, AbbVie’s second thoughts and Lilly’s lesson

Jan. 16, 2025, 1:56 p.m.

No Paywall
Picture of BioPharma Dive
BioPharma Dive
Website logo

At JPM, Biogen CEO tries to take down the deal temperature

Jan. 15, 2025, 4:52 p.m.

No Paywall
Picture of BioPharma Dive
BioPharma Dive
Website logo

J&J files a potential blockbuster; Lykos shakes up its board

Jan. 15, 2025, 4:45 p.m.

No Paywall
Picture of BioPharma Dive
BioPharma Dive
Website logo

Federal watchdog cites concerns with FDA’s accelerated approval process

Jan. 15, 2025, 4:26 p.m.

No Paywall
Picture of BioPharma Dive
BioPharma Dive
Website logo

JPM25: Amgen’s defense, Merck’s patent ‘hill’ and Viking’s long-term planning

Jan. 14, 2025, 11:04 p.m.

No Paywall
Picture of BioPharma Dive
BioPharma Dive
Website logo

Lilly blames slower-than-expected growth for 2024 sales miss

Jan. 14, 2025, 5:15 p.m.

No Paywall
Picture of BioPharma Dive
BioPharma Dive
Website logo

Regenxbio licenses gene therapies to Japan’s Nippon Shinyaku

Jan. 14, 2025, 4:30 p.m.

No Paywall
Picture of BioPharma Dive
BioPharma Dive
Website logo

5 questions facing emerging biotech in 2025

Jan. 14, 2025, 10 a.m.

No Paywall
Picture of BioPharma Dive
BioPharma Dive
Website logo

JPM25: Deals, Summit’s bravado and gene therapy headwinds

Jan. 13, 2025, 10:30 p.m.

No Paywall
Picture of BioPharma Dive
BioPharma Dive
Website logo

Biogen’s ‘cold and calculated’ offer to buy Sage receives a mixed reaction on Wall Street

Jan. 13, 2025, 5:07 p.m.

No Paywall
Picture of BioPharma Dive
BioPharma Dive
Website logo

Moderna shares tumble on slashed sales guidance

Jan. 13, 2025, 4:58 p.m.

No Paywall